Achieve Life Sciences Inc.
ACHV | NASDAQ
$8.35
+$0.30 (+3.73%)
Sep 22, 2026, 12:44 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.98 | -2.84 | -2.75 | -0.62 | -1.92 | -1.50 |
PEG Ratio | -4.93 | 0.16 | 0.04 | 0.25 | 0.08 | 0.02 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 10.07 | 5.40 | -56.41 | 3.13 | 2.25 | 0.59 |
P/FCF Ratio | -4.38 | -3.79 | -3.33 | -0.69 | -2.15 | -1.63 |
P/OCF Ratio | -4.38 | -3.79 | -3.34 | -0.69 | -2.15 | -1.63 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.69 | 0.48 | -11.55 | 1.95 | 0.53 | 0 |
Quick Ratio | 4.39 | 5.46 | 0.82 | 1.27 | 9.80 | 12.60 |
Current Ratio | 4.39 | 5.46 | 0.82 | 1.27 | 9.80 | 12.60 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -67.01 | -17.92 | -9.55 | -22.81 | n/a | n/a |
Return on Equity | -253.96% | -190.57% | 2.06K% | -510.06% | -118.22% | -39.32% |
Return on Assets | -130.77% | -103.09% | -153.92% | -141.30% | -69.77% | -36.38% |
Return on Invested Capital | -150.47% | -122.07% | -178.30% | -166.52% | -76.90% | -39.38% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ACHV